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Soft tissue sarcomas of the upper extremity represent a severe threat for the patient 
and a difficult task for the treatment team. Due to the complex anatomy of the arm, 
most sarcomas involve valuable functional structures. Nonetheless, a large portion of 
the patients can be treated in a limb-sparing manner, and surgery is the mainstay of 
local tumor control. This review gives an overview of the disease entities and their epide-
miology, on necessary patient work-up, staging, and imaging modalities, as well as the 
importance of interdisciplinary decision-making. The surgical therapies and principles 
of tumor excision are outlined, as well as reconstructive options. Furthermore, adjuvant 
treatments are discussed with a special focus on the various application techniques for 
radiation therapy. In spite of established treatment algorithms, each case is an individual 
challenge and individually tailored therapy is required. This aspect is illustrated by pre-
senting three comprehensive cases demonstrating useful strategies. A summary of the 
relevant literature is given.
Keywords: soft tissue sarcoma, plastic-reconstructive surgery, upper extremity reconstruction
iNTRODUCTiON
Soft tissue sarcomas (STS) are a heterogeneous group of rare malignant mesenchymal tumors rep-
resenting <1% of newly diagnosed solid tumors a year (1). They have an annual incidence of two to 
three cases per 100,000 (2). Although sarcomas can occur throughout the body, 60% of STS in adults 
occur in the limbs (15% in the upper extremity and 45% in the lower extremity) (3). One-fifth of all 
STS occur in the upper extremity (4). Therefore, this condition is very rare, and consequently, the 
literature is limited to small case series (5–9). Compared to the lower extremity, where liposarcoma 
and myxoid sarcoma are commonly encountered; synovial sarcoma, epithelioid sarcoma, and fibro-
sarcoma are relatively more common in the upper extremity (10).
Treatment of upper extremity STS presents a major challenge as the complex anatomy and high 
functional demands compete with oncological safety demands. Until the 1970s, extremity STS often 
required limb amputation due to high rates of local recurrence (11, 12). Nowadays, limb-sparing 
surgery can be performed in more than 90% of the patients without compromise in local recur-
rence rates or survival rates (8, 13). This development reflects the success of a modern treatment 
concept with a multidisciplinary team approach (7, 14–18). However, surgical resection remains the 
cornerstone of treatment, and surgical resection margins are the main prognostic factor for local and 
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systemic tumor control (6, 8, 19). In this review, we highlight key 
principles of oncological and reconstructive surgery of the upper 
extremity with focus on the upper arm and the forearm.
DiAGNOSTiC AND STAGiNG wORK-UP
Patients usually present with a subcutaneous tumor discovered 
by palpation. STS of the upper extremity are more readily noticed 
by the patient compared to the lower extremity. The estimation 
of duration and progression of the tumor is often uncertain, and 
there is no association to traumatic injury. The clinical behavior 
of STS is mostly misleading as they are characterized by slow 
growth, few physical complaints, and harmless appearance in 
cross-sectional imaging (20). However, due to the anatomic 
proximity of functional and neurovascular structures at the 
upper extremity complains of nerve involvement or functional 
impairment at first presentation are more common than in the 
lower extremity. Due to these circumstances, tumors of the upper 
extremity tend to be smaller at the time of presentation. In any 
case, every refractory swelling that is not recurrent after 4 weeks 
should initiate diagnostic work-up, as described and discussed in 
this article and elsewhere (21).
It is generally recommended that STS should be treated 
in tumor centers (16, 22–28). However, given the rarity and 
diversity of these tumors, it is not surprising that excisions are 
often performed without preoperative suspicion of malignancy 
and adequate preoperative diagnostic and staging work-up (22, 
26, 29). Tumors of the upper extremity are twice as likely to 
undergo unplanned excision, probably because of their smaller 
size and more superficial location (30). In our own patient col-
lectively, more than 50% of the patients are referred after such 
a procedure for further treatment. As shown, resection margins 
and histopathological assessments from referring institutions are 
often unreliable and unsuitable for further treatment planning. 
Moreover, especially in the upper extremity, the risk for residual 
tumor after unplanned primary excision is high. Although tumors 
are usually smaller than in the lower extremity, complex regional 
anatomy may be the reason for close margins or positive mar-
gins, necessitating more frequently postoperative radiotherapy. 
There is significantly more frequent residual disease and local 
recurrence in the upper extremity, especially around the elbow 
(10). Completion of diagnostic and staging work-up followed by 
re-excision is required in this patient group.
Contrast-enhanced MRI represents the standard procedure of 
diagnostic imaging, as it provides a detailed three-dimensional 
anatomic presentation of the tumor. With this information, tumor 
biopsy and excision can be planned (20, 31). A diagnosis can only 
be achieved by histopathological examination of a representative 
tumor sample. Therefore, excisional (only for small, superficial 
tumors) or incisional/punch biopsy has to be performed, as 
described elsewhere (21, 32). Second opinion reference-center 
pathology should be indicated generously.
Additionally, before a definitive treatment plan is established, 
completion of the clinical staging is mandatory. The assessment of 
tumor size, nodal status, and presence of metastasis has to be per-
formed (TNM status) (33). A spiral CT of the thorax is indicated, 
as STS are primarily characterized by pulmonary metastasis. 
However, at the time of diagnosis, only 10% of the patients pre-
sent with pulmonary metastasis (34). Only rarely, adult type STS 
metastasize to regional lymph nodes. Nevertheless, there are 
some sarcoma subtypes (synovial sarcoma, vascular sarcomas, 
rhabdomyosarcomas, and epithelioid and clear cell sarcomas) 
with a higher probability of lymphatic spread. However, the role 
of sentinel lymph node biopsy in these sarcoma subtypes is still 
unclear (35, 36). Although positron emission tomography (FDG–
PET) has not been yet established as standard imaging modality, 
it has some relevant advantages. As a functional imaging pro-
cedure, FDG–PET provides, besides the metastatic situation of 
the whole body, data on tumor activity and treatment response 
after neoadjuvant treatment. However, limited experience, avail-
ability, and examination costs are actually restricting factors for 
standardized use (37).
TUMOR BOARD Review
Categorization of the patients takes place according to the 
American Joint Committee on Cancer/International Union 
against Cancer classification (33, 38). A thorough treatment plan 
is determined in an interdisciplinary tumor board setting, includ-
ing oncosurgical, reconstructive, neoadjuvant, and adjuvant 
treatment options.
PROGNOSTiC FACTORS
Complete tumor resection is the most important prognostic 
factor for local and distant disease control (8, 9). If local tumor 
control is not achieved, there can be no successful treatment. 
Similarly, the general patient outcome is strongly correlated to 
distant metastasis. In case of insufficient primary excision and 
evidence of residual tumor, maximum effort should be made 
to achieve complete resection by re-excision. Re-excision has 
to include all previous incisions and drainage exit sites as well 
as every anatomic compartment suspicious for contamination. 
Furthermore, the presentation status, whether it is a primary or 
recurrent tumor, as well as the tumor size (<5 or >5 cm), tumor 
grading, and extracompartimental location are relevant prognos-
tic factors (8, 9). The specific anatomic tumor location is also a 
relevant factor: for example, tumor location at the shoulder girdle 
hampers limb-sparing surgery (39–41). As previously stated, 
residual disease and recurrence are more common in the upper 
extremity. Besides anatomical factors, this is also due to the fact 
that histological entities, which are more common in the upper 
extremity (angiosarcoma, malignant peripheral nerve sheath 
tumor), are associated with a higher risk of recurrence (42) that 
more frequent tumors of the lower extremity, such as low grade 
liposarcoma.
ONCOSURGiCAL ReSeCTiON
The extent of surgical margins is subject of discussion, as there 
is no solid evidence. The trend during the past decades has been 
directed toward reduction of the margins (43, 44). The most fre-
quent type of excision is termed “wide excision,” signifying that 
the tumor is to be removed within healthy tissue, in the manner 
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that the tumor is not seen by the surgeon. Contrastingly, the 
so-called “marginal excision” (excision at the level of the tumor 
capsule) is not adequate since it does not include a macroscopic 
layer of uninvolved tissue, which is required by the pathologist in 
order to certify an R0 status. Resection of the entire compartment, 
involving all muscles from their origin to the insertion is largely 
historical and is rarely required. Recently, the type of connective 
tissue involved was a topic of interest, as sarcomas grow along, 
rather than transverse, major fascial planes. This enables preser-
vation of major nerves, bones, and muscles with <1 cm resection 
margin, when fascial planes can be included in the resection 
(45). Microsurgical techniques enable us to maintain the balance 
between radical resection and preservation of function. Tumor 
invasion of nerves is a rare occurrence. In case of close proximity to 
the tumor, epineural dissection is a safe option (46). Furthermore, 
neoadjuvant, intraoperative (IORT), or adjuvant radiotherapy 
treatment modalities additionally contributed to the reduction of 
resection margins. However, when neurovascular or functional 
structures cannot be preserved, the oncosurgical defects have to 
be incorporated into the reconstructive plan.
In cases of advanced disease and extensive infiltration, ampu-
tation of the limb is required. Also in these cases, there are useful 
reconstructive options, such as composite-tissue elbow transfer 
for reconstruction of the shoulder silhouette (41). In order to 
offer consultation to these patients, the surgeon also needs to be 
aware of the current advances in bionic prosthetics, which is a 
rapidly evolving field offering good solutions. The resected speci-
men should be clearly marked with sutures and the correspond-
ing sites in the tumor bed with clips. An intraoperative biopsy 
examination is generally not recommended.
ReCONSTRUCTiON
Whenever possible, reconstruction should be achieved as a one-
step procedure during tumor excision. Otherwise, wound closure 
by vacuum-assisted closure can be an alternative, especially when 
resection margins are uncertain.
The goal of reconstruction is to provide reconstruction of 
every resected tissue and the related function and to achieve 
primary wound healing in the interest of timely rehabilitation 
and adjuvant therapy. In modern reconstructive surgery, it is not 
sufficient to merely achieve wound closure. It is just as important 
to strive for optimal functional and esthetic results. For example, 
split-thickness skin grafts can be transplanted on vital muscle 
tissue with success. However, this will not lead to an esthetically 
pleasing result, and it can possibly cause extensive wound heal-
ing problems, especially if tendons are exposed. In our patients, 
almost 70% of the patients with upper extremity sarcoma require 
reconstructive surgery, compared to 50% at the lower extrem-
ity. Reconstructive techniques are more often required in the 
distal parts of an extremity. In most of these patients, the whole 
reconstructive armamentarium has to be utilized (16, 18). Due to 
small case numbers, there is no evidence supporting the use of 
individual reconstructive techniques, so that the plastic surgeons 
use the traditional “reconstructive-ladder” when devising the 
treatment plan. It is, however, common for experienced surgeons, 
especially in the light of increasing expertise and confidence in 
free-flap surgery, to skip one or more ladders in the decision-
making process.
Several authors have reported that local or regional flaps 
are associated with higher complication rates and have inferior 
functional results compared to free flaps (7, 47), which is also our 
own experience. Some authors found that free-flap reconstruc-
tion after soft tissue sarcoma excision at the upper extremity is 
associated with increased morbidity but better local control (48). 
Others found that functional outcome achieved satisfactory levels 
with both pedicled and free flaps (49).
Proximal upper extremity can be successfully treated with 
traditional random-pattern flaps or axial-pattern flaps originat-
ing from the extremity (lateral upper arm flap) or the shoulder 
(subscapular vascular territory). Axial flaps, such as dorsal 
interosseous flap, can be used on the forearm. Local flaps that 
compromise one of the major vessels, such as the pedicled radial 
artery flap, are not recommended any more due to extensive 
donor-site morbidity.
There are several free-flap options with minimal donor-site 
issues, which are used routinely. Since there is no advantage in 
using a muscle flap and since there are several good perforator 
flaps available, the perforator flaps have become the mainstay of 
modern reconstructive surgery. The workhorse flap for extremity 
reconstruction is the anterolateral thigh (ALT) flap (17), which 
enables a two-team parallel approach in the supine position. The 
parascapular flap is another good alternative, requiring surgery in 
the lateral position. The thoracodorsal artery perforator (TDAP) 
flap or the musculocutaneous latissimus-dorsi (LD) flap is avail-
able for larger defects.
Functional reconstruction of nerve defects (commonly using 
sural nerve grafting) or blood vessel interposition is also per-
formed at this stage. If there is a tendon defect and the muscle can 
be preserved, free tendon transplants are performed, usually using 
the palmaris longus or plantaris tendon. If the muscle has to be 
sacrificed, the first-line solutions available are the classical tendon 
transfers, e.g., radial nerve palsy tendon transfer (50). Functional 
free flaps are rarely required. In this case, free functional gracilis 
transfer is the primary option, e.g., for reconstruction of finger 
flexion, as shown in case 3.
ADJUvANT THeRAPY
Radiation Therapy
Radiation therapy is almost always used as neoadjuvant therapy. 
The only indication for radiation monotherapy is rare cases that 
are deemed inoperable because of significant comorbidities. 
Using the combination of surgical and radiation therapy, 90–95% 
rates of limb salvage can be achieved. Radiation is usually admin-
istered as adjuvant therapy, in a combined dosage of 60–66 Gy 
with conventional fractionation. The field of radiation includes 
the tumor bed, margin of safety, as well as scars from previous 
operations and drainage exit sites. In this way, an improvement of 
local control for G2 and G3 STS can be achieved. Radiation for G1 
tumors is not indicated after R0 resection. Adjuvant radiation can 
negatively influence complex reconstruction, so that high-grade 
sarcoma requiring extensive surgery should preferably be treated 
FiGURe 1 | Case 1: (A) clinical visible mass in the right axilla, pre-OP drawing of the wide resection margins. (B) Pre-OP drawing demonstrates planned 
pedicled parascapular fasciocutaneous flap. (C) Pre-OP MRI of the right axilla. (D) Intraoperative situation after wide en-bloc excision of tumor. Deep margins were 
achieved by epineurectomy and adventitiectomy. (e) Pedicled parascapular flap inset reconstructs the defect. (F) Clinical appearance 5 years after surgery and 
external post-OP radiation therapy.
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FiGURe 2 | Case 2: (A) pre-OP picture shows mass in the proximal forearm. (B) Intra-OP situation after wide en-bloc excision. (C) Intra-OP application of 
radiation therapy in the wound bed close to the ulna (15 Gy). (D) Raised anterolateral thigh flap from the left leg for microvascular reconstruction. (e) Clinical 
appearance of the reconstructed forearm 1 year after additional external radiation therapy (50.4 Gy).
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with neoadjuvant radiation (51). Neoadjuvant radiation has com-
parable effects on local disease control as adjuvant therapy. The 
advantages are that the field of radiation can be kept smaller, and 
the dosage required (50 Gy) is lower. The often discussed severe 
postoperative wound healing complications after neoadjuvant 
radiotherapy are much more frequent in the lower extremity (52). 
Thus in the upper extremity, this strategy can be applied more 
liberally by taking advantage of the smaller irradiation field and 
dose. Intraoperative radiation therapy is always used in addition 
to neoadjuvant radiation therapy, the dosage of which can be 
reduced accordingly. Usually, 12–15 Gy are administered to the 
tumor bed (case 2).
Chemotherapy
Most types of STS are not very sensitive to chemotherapy, with 
exception of small-round-blue-cell tumors, extraosseous Ewing 
sarcoma, rhabdomyosarcoma, primitive neuroectodermal tumor, 
and desmoplastic small-round-cell tumor. Despite an increase in 
experimental data, there is still limited application of molecular-
targeted therapy for treatment of STS. Two examples of successful 
targeted therapy are the use of imatinib in treatment of dermatofi-
brosarcoma protuberans and the use of sorafenib in treatment of 
angiosarcoma. The use of standard chemotherapeutics, such as 
anthracyclines or ifosfamide after R0 resection, is not generally 
recommended.
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Hyperthermia and isolated 
Limb Perfusion
The combination of neoadjuvant or adjuvant chemotherapy 
and regional hyperthermia, possibly with additional radiation 
therapy, can improve local disease control in locally advanced 
tumors. Isolated limb perfusion with tumor necrosis factor alpha 
or melphalan can be considered in tumors, which cannot be 
resected with R0 margins, or when surgical excision would lead 
to mutilating loss of function.
CONCLUSiON
To achieve optimal outcomes, treatment of STS of the upper 
extremity should be carried out at experienced institutions where 
FiGURe 3 | Case 3: (A) MRi left forearm before radiation. (B) MRI left forearm post radiation. (C) H&E specimen showing only few scattered remaining tumor 
cells as a result of the preoperative radiotherapy. (D) Intraoperative situation after en-bloc excision of the flexor compartment. (e) Intraoperative detail photography 
of the transected median nerve. The blue marking shows the motor branch to the deep flexors, later used for nerve coaptation to the obturator branch of the 
transferred gracilis muscle. (F) Gracilis muscle after microvascular transfer and motor nerve coaptation. After defining the proper tension, the muscle will be fixed to 
the deep flexor tendons (II–V). Flexor pollicis longus function was reconstructed using a brachioradial tendon transfer. (G,H) Clinical result 5 years after therapy. 
There is a remaining extension deficit, but a full finger flexion with a strong grip could be achieved. Patient is in complete remission and rehabilitated in his original job 
as a truck driver.
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all relevant disciplines are represented. Each sarcoma has its spe-
cific histopathological phenotype, grading, size, and, importantly, 
specific anatomical localization within the complex anatomy of 
the arm.
Nevertheless, widely accepted treatment principles exist that 
can be adapted to the individual situation. Prior to treatment, it 
is mandatory to discuss the case in a multidisciplinary confer-
ence defining the use and the sequence of treatment modalities. 
The mainstay of local tumor control – the prerequisite for curing 
the patient – is surgery. A radical oncosurgical approach in the 
upper extremity requires plastic-reconstructive procedures in 
more than 70% of the cases. The continuously expanding plastic-
surgical options for reconstruction of surface, volume, and func-
tion enable surgeons to customize the oncosurgical procedure 
and to preserve the upper extremity with a good oncological and 
functional result in most of the cases.
CASe DeMONSTRATiONS
Case 1 (Figure 1) demonstrates the case of a 64-year-old male 
patient suffering from a high-grade pleomorphic sarcoma in the 
right axilla (T2b, N0, M0, G3). A wide excision was planned and 
carried out with sufficient removal of skin and subcutaneous tis-
sue due to the extracompartimental localization of the sarcoma. 
Margins to the deep structures of the axilla could be achieved by 
thorough dissection of the nerve and vessel sheaths. The transfer 
of a pedicled parascapular flap was performed in the same opera-
tion. Noteworthy, we dissect the pedicle completely back through 
the medial axillary gap, ligating the osseous branches of the cir-
cumflex scapular artery. The flap can be advanced through this 
tunnel, allowing a completely tension-free placement in the axilla. 
The patient is shown 5 years after surgery and post-OP radiation 
therapy with an excellent functional result. The parascapular flap 
delivers sufficient pliable soft tissue coverage avoiding functional 
impairment of shoulder movement (53–55).
Case 2 (Figure  2) shows a 47-year-old female patient with 
fast recurrence of an incompletely resected high-grade sarcoma 
of the left forearm (pleomorphic sarcoma, initially T1b, N0, M0, 
G3). She had underwent the so-called “whoops procedure” – a 
term referring to an unplanned sarcoma resection where no 
malignancy had been suspected. A wide resection was per-
formed with partial removal of the ulnar periosteum. The deep 
tumor bed was treated with an internal radiation therapy with 
the application of 15 Gy, thus reducing the post-OP dose from 
65 to 50 Gy. Distal to the elbow, large defects are difficult to cover 
with local tissue transfer. The transfer of a free-flap offers an 
elegant option to avoid additional morbidity in proximity to the 
tumor region. The demonstrated ALT flap is one of the “work-
horse” microvascular flaps in reconstructive tumor surgery of 
the extremities (17).
Case 3 (Figure 3) shows a 29-year-old patient with an epithe-
lioid cell sarcoma (T2b, N0, M0, G3) of the left forearm within the 
flexor compartment. Crucial structures (flexor muscles, median 
nerve, and radial artery) are involved. When complex functional 
reconstruction of those structures is necessary, postoperative 
radiation therapy should be avoided, which is why preoperative 
radiation therapy (50 Gy) was conducted in this case. The MRI 
pre- and postradiation do not differ much in tumor size, but a 
significant reduced contrast enhancement can be demonstrated. 
Histology reflects good response to radiation therapy with 
only few vital, scattered tumor cells. Radical resection was car-
ried out with en-bloc removal of all flexors (except FCU), the 
median nerve, and the radial artery. Sensory reconstruction was 
performed via multiple sural nerve cable grafts, which resulted 
in recovery of protection sensation. Functional reconstruction 
for the flexors was achieved with a free microvascular, functional 
gracilis muscle transfer, covered with a split-thickness skin 
graft (56). The patient has recovered quite well from this radical 
approach and is rehabilitated in his former job as truck driver. 
In the upper extremity, much less wound healing complications 
arise from this sequence of treatment modalities, especially when 
free tissue transfer is performed. In the lower extremity, there is 
a higher occurrence of severe wound healing complications after 
preoperative radiation.
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